{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T08:52:54Z","timestamp":1768639974098,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81401361"],"award-info":[{"award-number":["81401361"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.cellimm.2018.04.011","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T17:51:07Z","timestamp":1524765067000},"page":"41-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Class I PI3K inhibitor ZSTK474 attenuates experimental autoimmune neuritis by decreasing the frequency of Th1\/Th17 cells and reducing the production of proinflammatory cytokines"],"prefix":"10.1016","volume":"329","author":[{"given":"Xiuju","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranran","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanchao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dexin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7032-4033","authenticated-orcid":false,"given":"Xiaofeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2018.04.011_b0005","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.mayocp.2016.12.002","article-title":"Guillain-Barre syndrome","volume":"92","author":"Wijdicks","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.cellimm.2018.04.011_b0010","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barre syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellimm.2018.04.011_b0015","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","article-title":"Immunotherapy for Guillain-Barre syndrome: a systematic review","volume":"130","author":"Hughes","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.cellimm.2018.04.011_b0020","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1212\/WNL.0b013e3182904fcc","article-title":"Mortality in Guillain-Barre syndrome","volume":"80","author":"van den Berg","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.cellimm.2018.04.011_b0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/(SICI)1097-4547(19990415)56:2<123::AID-JNR2>3.0.CO;2-G","article-title":"IFN-beta suppresses experimental autoimmune neuritis in Lewis rats by inhibiting the migration of inflammatory cells into peripheral nervous tissue","volume":"56","author":"Zou","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.cellimm.2018.04.011_b0030","doi-asserted-by":"crossref","first-page":"e38157","DOI":"10.1371\/journal.pone.0038157","article-title":"Attenuated EAN in TNF-alpha deficient mice is associated with an altered balance of M1\/M2 macrophages","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cellimm.2018.04.011_b0035","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/mus.20076","article-title":"Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system","volume":"30","author":"Kieseier","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cellimm.2018.04.011_b0040","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cellimm.2011.08.015","article-title":"Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1\/Th17 cytokines and up-regulated T regulatory cells","volume":"271","author":"Li","year":"2011","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cellimm.2018.04.011_b0045","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/jnci\/djj133","article-title":"Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor","volume":"98","author":"Yaguchi","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cellimm.2018.04.011_b0050","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/aps.2010.150","article-title":"ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor identified using the JFCR39 drug discovery system","volume":"31","author":"Kong","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cellimm.2018.04.011_b0055","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00011-012-0444-8","article-title":"Inhibitory effects of ZSTK474, a phosphatidylinositol 3-kinase inhibitor, on adjuvant-induced arthritis in rats","volume":"61","author":"Haruta","year":"2012","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.cellimm.2018.04.011_b0060","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1186\/ar3019","article-title":"Inhibitory effects of ZSTK474, a novel phosphoinositide 3-kinase inhibitor, on osteoclasts and collagen-induced arthritis in mice","volume":"12","author":"Toyama","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cellimm.2018.04.011_b0065","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00109-014-1158-x","article-title":"ZSTK474, a novel PI3K inhibitor, modulates human CD14+ monocyte-derived dendritic cell functions and suppresses experimental autoimmune encephalomyelitis","volume":"92","author":"Xue","year":"2014","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.cellimm.2018.04.011_b0070","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12974-016-0660-1","article-title":"Class I PI3K inhibitor ZSTK474 mediates a shift in microglial\/macrophage phenotype and inhibits inflammatory response in mice with cerebral ischemia\/reperfusion injury","volume":"13","author":"Wang","year":"2016","journal-title":"J. Neuroinflam."},{"key":"10.1016\/j.cellimm.2018.04.011_b0075","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2174\/138955707781387948","article-title":"FTY720: a most promising immunosuppressant modulating immune cell functions","volume":"7","author":"Zhang","year":"2007","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.cellimm.2018.04.011_b0080","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1471-4159.2006.04309.x","article-title":"Lovastatin attenuates nerve injury in an animal model of Guillain-Barre syndrome","volume":"100","author":"Sarkey","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cellimm.2018.04.011_b0085","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/icb.2013.81","article-title":"Glatiramer acetate ameliorates experimental autoimmune neuritis","volume":"92","author":"Zhang","year":"2014","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.cellimm.2018.04.011_b0090","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12974-016-0559-x","article-title":"Dimethyl fumarate attenuates experimental autoimmune neuritis through the nuclear factor erythroid-derived 2-related factor 2\/hemoxygenase-1 pathway by altering the balance of M1\/M2 macrophages","volume":"13","author":"Han","year":"2016","journal-title":"J. Neuroinflam."},{"key":"10.1016\/j.cellimm.2018.04.011_b0095","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/cns.12498","article-title":"Expression profile of long noncoding RNAs in peripheral blood mononuclear cells from multiple sclerosis patients","volume":"22","author":"Zhang","year":"2016","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.cellimm.2018.04.011_b0100","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.4049\/jimmunol.0901088","article-title":"Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects","volume":"183","author":"Zhang","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2018.04.011_b0105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/ni0403-313","article-title":"The role of PI3K in immune cells","volume":"4","author":"Koyasu","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2018.04.011_b0110","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1182\/blood-2009-07-232330","article-title":"PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans","volume":"115","author":"Soond","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2018.04.011_b0115","first-page":"882","article-title":"PI3K signalling in inflammation","volume":"2015","author":"Hawkins","year":"1851","journal-title":"BBA"},{"key":"10.1016\/j.cellimm.2018.04.011_b0120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.coph.2015.05.017","article-title":"PI3K inhibitors in inflammation, autoimmunity and cancer","volume":"23","author":"Stark","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.cellimm.2018.04.011_b0125","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.4049\/jimmunol.1601083","article-title":"Programmed death ligand 1 plays a neuroprotective role in experimental autoimmune neuritis by controlling peripheral nervous system inflammation of rats","volume":"197","author":"Ding","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2018.04.011_b0130","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jaci.2013.03.015","article-title":"Mechanisms underlying helper T-cell plasticity: implications for immune-mediated disease","volume":"131","author":"Hirahara","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cellimm.2018.04.011_b0135","doi-asserted-by":"crossref","first-page":"e90942","DOI":"10.1371\/journal.pone.0090942","article-title":"Erythropoietin-derived nonerythropoietic peptide ameliorates experimental autoimmune neuritis by inflammation suppression and tissue protection","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cellimm.2018.04.011_b0140","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","article-title":"Th1\/Th2\/Th17\/Treg cytokines in Guillain-Barre syndrome and experimental autoimmune neuritis","volume":"24","author":"Zhang","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.cellimm.2018.04.011_b0145","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1517\/14728222.2014.882899","article-title":"Can IFN-gamma be a therapeutic target in Guillain-Barre syndrome?","volume":"18","author":"Zhang","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.cellimm.2018.04.011_b0150","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3109\/08923973.2012.697469","article-title":"Th17 helper cell and T-cell immunoglobulin and mucin domain 3 involvement in Guillain-Barre syndrome","volume":"34","author":"Liang","year":"2012","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.cellimm.2018.04.011_b0155","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2990.2009.01016.x","article-title":"FTY720 attenuates lesional interleukin-17(+) cell accumulation in rat experimental autoimmune neuritis","volume":"35","author":"Zhang","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.cellimm.2018.04.011_b0160","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/jnr.23233","article-title":"Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barre syndrome as well as their animal models","volume":"91","author":"Wang","year":"2013","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.cellimm.2018.04.011_b0165","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/sji.12201","article-title":"Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis","volume":"80","author":"Wang","year":"2014","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.cellimm.2018.04.011_b0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.expneurol.2008.11.014","article-title":"Distribution of Foxp3(+) T-regulatory cells in experimental autoimmune neuritis rats","volume":"216","author":"Zhang","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cellimm.2018.04.011_b0175","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.4049\/jimmunol.177.8.5122","article-title":"The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells","volume":"177","author":"Okkenhaug","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2018.04.011_b0180","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1182\/blood-2006-07-038620","article-title":"T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling","volume":"109","author":"Deane","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2018.04.011_b0185","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.celrep.2012.02.007","article-title":"PI3K-Akt-mTORC1-S6K1\/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORgamma","volume":"1","author":"Kurebayashi","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellimm.2018.04.011_b0190","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ni.2005","article-title":"The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2","volume":"12","author":"Delgoffe","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2018.04.011_b0195","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/83144","article-title":"Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-gamma but not TH2 cytokines","volume":"2","author":"Kane","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cellimm.2018.04.011_b0200","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1111\/j.1349-7006.2007.00580.x","article-title":"ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms","volume":"98","author":"Kong","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cellimm.2018.04.011_b0205","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.4049\/jimmunol.178.8.4901","article-title":"Stat3 and Stat4 direct development of IL-17-secreting Th cells","volume":"178","author":"Mathur","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2018.04.011_b0210","doi-asserted-by":"crossref","first-page":"e0117081","DOI":"10.1371\/journal.pone.0117081","article-title":"Ghrelin inhibits the differentiation of T helper 17 cells through mTOR\/STAT3 signaling pathway","volume":"10","author":"Xu","year":"2015","journal-title":"PLoS One"}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874918301862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874918301862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T17:19:22Z","timestamp":1741713562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874918301862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":42,"alternative-id":["S0008874918301862"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2018.04.011","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Class I PI3K inhibitor ZSTK474 attenuates experimental autoimmune neuritis by decreasing the frequency of Th1\/Th17 cells and reducing the production of proinflammatory cytokines","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2018.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}